Skip to main content
Clinical Trials/NCT01335152
NCT01335152
Completed
Phase 1

Coping With Breast Cancer and Treatment: An E-Learning Course for Skills and Strategies

Talaria, Inc1 site in 1 country100 target enrollmentApril 2010
ConditionsBreast Cancer

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Talaria, Inc
Enrollment
100
Locations
1
Primary Endpoint
PHQ GAD-7 - Anxiety
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Stress Management interventions have been shown to decrease cancer-related distress, foster emotional growth and improve immune functioning during treatment for breast cancer.

This study will evaluate an online version of a stress management intervention for women with early stage breast cancer. Each chapter of the 10-week intervention include self-assessment and targeted feedback, education, interactive learning exercises -- all tailored to the needs of women with early stage breast cancer. In addition, guided writing exercises will promote emotional expression and a discussion board will encourage group support.

The web-based intervention is being evaluated in a randomized clinical trial with a sample of 120 women with early stage breast cancer. Women will be randomly assigned to use the 10-week intervention with biweekly telephone assessments or to the telephone assessments alone.

Detailed Description

Stress Management interventions have been shown to decrease cancer-related distress, foster emotional growth and improve immune functioning during treatment for breast cancer. This study will evaluate an online version of a stress management intervention for women with early stage breast cancer. Each chapter of the 10-week intervention include self-assessment and targeted feedback, education, interactive learning exercises -- all tailored to the needs of women with early stage breast cancer. In addition, guided writing exercises will promote emotional expression and a discussion board will encourage group support. The web-based intervention is being evaluated in a randomized clinical trial with a sample of 120 women with early stage breast cancer. Women will be randomly assigned to use the 10-week intervention with biweekly telephone assessments or to the telephone assessments alone.

Registry
clinicaltrials.gov
Start Date
April 2010
End Date
August 2011
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of stage 0, I, II or III breast cancer within past 18 months
  • Elevated stress, distress or negative mood
  • Access at least 1.5 - 2 hours per week to a computer with audio capabilities that is connected to the internet
  • Ability to read, write, and speak English at a sixth grade level
  • Access to a telephone and an active e-mail account

Exclusion Criteria

  • Cancer diagnosis is a recurrence
  • Diagnosis of schizophrenia
  • Use of anti-psychotic medication
  • Diagnosis of bipolar disorder without use of mood stabilizing medication

Outcomes

Primary Outcomes

PHQ GAD-7 - Anxiety

Time Frame: baseline, post-intervention, follow-up

7-item self-report questionnaire measureing anxiety.

CES-D 10

Time Frame: baseline, post-intervention, follow-up

10 item self-report measure of depression.

FACT-B: Functional Assessment of Cancer Therapy - Breast

Time Frame: baseline, post-intervention, follow-up

44 item self-report measure of health related quality of life for breast cancer patients.

Secondary Outcomes

  • Revised Impact of Event Scale(baseline, post-intervention, follow-up)
  • Benefit Finding Scale for breast cancer(baseline, post-intervention, follow-up)
  • CANCER BEHAVIOR INVENTORY (CBI-B)(baseline, post-intervention, follow-up)

Study Sites (1)

Loading locations...

Similar Trials